We are live on ! Find out more
EAM

Exome Asset Management Portfolio holdings

AUM $193M
1-Year Est. Return 208.51%
This Fund
S&P 500
This Quarter Est. Return
+10.44%
1 Year Est. Return
+208.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$22M
Cap. Flow
+$60.5M
Cap. Flow %
44.95%
Top 10 Hldgs %
36.29%
Holding
86
New
27
Increased
9
Reduced
17
Closed
23

Top Buys

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$4.06M
2
VSTM icon
Verastem
VSTM
+$3.76M
3
PRAX icon
Praxis Precision Medicines
PRAX
+$2.25M
4
APLS
Apellis Pharmaceuticals
APLS
+$1.83M
5
UHS icon
Universal Health Services
UHS
+$1.82M

Top Sells

Rank Stock Value
1
AKRO
Akero Therapeutics
AKRO
+$3.47M
2
VRDN icon
Viridian Therapeutics
VRDN
+$2.93M
3
SVRA icon
Savara
SVRA
+$2.32M
4
AZN icon
AstraZeneca
AZN
+$2.28M
5
ANAB icon
AnaptysBio
ANAB
+$2.13M

Sector Composition

Rank Sector Weight
1 Healthcare 79.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
76
PUT
Roivant Sciences
ROIV
$23.6B
– –
-75,300
Closed -$15.1K
RYTM icon
77
PUT
Rhythm Pharmaceuticals
RYTM
$7.31B
– –
-40,000
Closed -$70K
SLNO
78
PUT
DELISTED
Soleno Therapeutics
SLNO
– –
-11,000
Closed -$275
SVRA icon
79
Savara
SVRA
$1.08B
– –
-836,397
Closed -$2.32M
SWTX
80
CALL
DELISTED
SpringWorks Therapeutics
SWTX
– –
-37,500
Closed -$129K
TRVI icon
81
Trevi Therapeutics
TRVI
$2.57B
– –
-163,738
Closed -$1.03M
VERU icon
82
CALL
Veru
VERU
$35.5M
– –
-6,000
Closed -$900
VRDN icon
83
Viridian Therapeutics
VRDN
$2.2B
– –
-217,294
Closed -$2.93M
ONC
84
BeOne Medicines Ltd
ONC
$33.9B
– –
-6,500
Closed -$1.77M
1 2 3
4

Similar funds

WWC
Waypoint Wealth Counsel Atlanta, Georgia $193M AUM 30.17% 1-Year Est. Return
JHA
Jackson Hill Advisors Houston, Texas $193M AUM 4.94% 1-Year Est. Return
TDWM
Topel & Distasi Wealth Management Berkeley, California $193M AUM 12.07% 1-Year Est. Return
DF
Downshift Financial Boulder, Colorado $193M AUM
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
PA
Promethium Advisors Bethesda, Maryland $193M AUM 23.69% 1-Year Est. Return
SCPM
Sea Cliff Partners Management San Francisco, California $194M AUM 8.22% 1-Year Est. Return
EWM
Evergreen Wealth Management Williamston, Michigan $194M AUM 13.93% 1-Year Est. Return

Exome Asset Management's Q2 2025 Portfolio in Review

As of Q2 2025, Exome Asset Management held 86 positions worth $135M, up 20% from $112M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Exome Asset Management deployed $60.5M of net new capital in Q2 2025, opening 27 new positions and adding to 9 existing holdings. Its largest new stake was Tenet Healthcare: 27,000 shares worth $4.75M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 98% a quarter earlier.

On the sell side, the largest reduction was AnaptysBio, an estimated $2.13M trimmed.

  • Exome Asset Management's largest Q2 2025 buy was Tenet Healthcare: 27,000 shares worth $4.75M.
  • Exome Asset Management added most to BioCryst Pharmaceuticals in Q2 2025, an estimated $1.05M increase.
  • Exome Asset Management's biggest Q2 2025 reduction was AnaptysBio, cutting an estimated $2.13M.
  • Exome Asset Management fully exited Akero Therapeutics in Q2 2025, selling an estimated $3.47M.
  • Exome Asset Management's ten largest holdings make up 36% of its $135M portfolio in Q2 2025.
  • Exome Asset Management opened 27 new positions and closed 23 in Q2 2025.
  • Exome Asset Management's portfolio value rose 20% quarter-over-quarter to $135M.

Based on Exome Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.